tiprankstipranks
Analyst Profile
Followed by 4 other investors
.
Suji Jeong

Suji Jeong

Jefferies
Wall Street Analyst
Ranked #7,583 out of 8,045 Analysts on TipRanks (#20,205 out of 21,519 overall experts)

Success Rate

25%
4 out of 16 Profitable Transactions

Average Return

-22.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Suji Jeong's ratings since 2019 and opened each position for the duration of 1 Year:
25.00% of your transactions would have been profitable with an average return of -22.4%

Stock Rating Distribution

18Ratings
94.44% Buy
5.56% Hold
0.00% Sell
Distribution of Suji Jeong's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Point Biopharma Global Inc.
(PNT)
Rating Type:Buy
Dates:Jun 24, 2022 - Jan 01, 1970
Gain:20.20%
The most profitable rating made by Suji Jeong

Suji Jeong's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Tempest Therapeutics
Sep 16, 2019
Buy
Initiated
$22.00
(783.53% Upside)
0%
-74.90%
1
Savara
Mar 05, 2020
Buy
Initiated
$5.00
(197.62% Upside)
0%
-37.50%
1
BELLUS Health
Jul 06, 2020
Buy
Reiterated
$6.00
(-49.83% Downside)
0%
-36.90%
2
Verona Pharma
Aug 25, 2020
Buy
Initiated
$17.00
(36.22% Upside)
0%
-19.40%
1
Stoke Therapeutics
Apr 04, 2022
Buy
Reiterated
$50.00
(133.10% Upside)
50%
+3.20%
2
Fusion Pharmaceuticals
May 26, 2022
Buy
Initiated
$19.00
(822.33% Upside)
0%
-42.30%
1
Inozyme Pharma
May 26, 2022
Hold
Reiterated
$5.00
(32.98% Upside)
0.00%
1
uniQure
Jun 23, 2022
Buy
Reiterated
$60.00
(188.74% Upside)
17%
-24.83%
7
POINT Biopharma Global
Jun 24, 2022
Buy
Reiterated
$20.00
(130.68% Upside)
100%
+15.90%
2
List of latest recommendations made by Suji Jeong. Click to expand and see Suji Jeong's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More